Related Experiment Video
Updated: May 5, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Severe Panton-Valentine-Leukocidin-Positive Staphylococcus aureus Infections in Pediatric Age: A Case Report and a
Valeria Garbo1, Laura Venuti1, Giovanni Boncori1
1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
Insights
Panton-Valentine leukocidin-producing Staphylococcus aureus (PVL-SA) can cause severe invasive infections in children. Pulmonary involvement significantly predicts the need for intensive care in pediatric PVL-SA cases.
Area of Science:
- Infectious Diseases
- Pediatrics
- Microbiology
Background:
- Panton-Valentine leukocidin-producing Staphylococcus aureus (PVL-SA) infections are increasingly recognized in community settings.
- These infections pose significant risks for severe disease in pediatric populations.
Purpose of the Study:
- To present a pediatric case of invasive PVL-SA disease.
- To review severe manifestations of PVL-SA in children.
- To identify predictors for intensive care unit (ICU) admission.
Main Methods:
- Literature search of PubMed (February 2024) for pediatric PVL-SA cases with clinical outcomes, diagnostics, and treatments.
- Exclusion of asymptomatic infections and adult cases.
- Multivariate logistic analysis to determine ICU predictors.
Main Results:
- A 10-year-old boy presented with necrotizing pneumonia, osteomyelitis, deep vein thrombosis (DVT), and abscesses due to PVL-producing methicillin-resistant Staphylococcus aureus (MRSA).
- Literature review of 156 pediatric cases revealed high rates of bacteremia (49%), lung infection (47%), and osteomyelitis (37%).
- Pulmonary involvement was a strong predictor for ICU admission (OR 25.35, p < 0.001).
Conclusions:
- PVL-SA can cause life-threatening complications in children, including severe pneumonia and sepsis.
- Pulmonary localization is a critical factor indicating the need for intensive care.
- Effective therapeutic strategies, including anti-toxin molecules, are crucial for managing severe PVL-SA infections.
Abstract:
Background: Infections caused by S. aureus strains encoding Panton-Valentine leukocidin (PVL-SA) have become increasingly relevant in community settings and can cause severe conditions in pediatric populations. We present the pediatric case of an invasive disease caused by PVL-SA and provide a literature review of severe manifestations caused by these strains in children. Methods: A PubMed search (February 2024) found studies that included relevant clinical outcomes, diagnostics, and treatments, excluding cases of asymptomatic infection or in adult populations. A logistical multivariate analysis was used to find predictors of the need for intensive care. Results: A 10-year-old boy came to the attention of our Pediatric Infectious Diseases Unit with fever, chest pain, and tachypnea. A rapid worsening of his clinical conditions was observed, with the development of necrotizing pneumonia, osteomyelitis, deep vein thrombosis (DVT), and multiple abscesses. Blood cultures confirmed the presence of PVL-producing methicillin-resistant S. aureus (MRSA). The initial treatment included linezolid and ceftaroline and was later adjusted to clindamycin, daptomycin, and fosfomycin, with clinical improvement. Discussion: Our review collected 36 articles, including 156 pediatric cases of severe PVL-SA infection. Bacteremia was present in 49% of cases, lung infection in 47%, and osteomyelitis in 37%. The presence of pulmonary localization was predictive of the need for intensive care, O.R. 25.35 (7.46-86.09; p < 0.001). Anti-toxin molecules were used in about half the cases where information on treatment was reported. Our report highlights the capacity of PVL-SA to cause life-threatening complications in children, while also discussing the full range of its clinical spectrum and the most effective therapeutic approaches.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance